CSF2 and acute lymphoblastic leukemia: Neutralization of GM-CSF with lenzilumab in patient-derived xenograft mouse model of B-ALL treated with CAR-T cells alleviates neuroinflammation and symptoms of CRS by reducing migration of myeloid and T-cell migration to the CNS (199).